BioNTech co-created the Pfizer COVID vaccine, now focused on cancer.
BioNTech SE (BNTX) is expected to report earnings on Tuesday, November 3, 2026, before the open. Estimated release time before open. Consensus EPS estimate is $0.89.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-04 | Jun 2026 qtr | $-2.40 | $-3.70 | — | $120.60M |
| 2026-05-05 | Mar 2026 qtr | $-2.54 | $-2.43 | +4.4% | $136.45M |
| 2026-03-10 | Dec 2025 qtr | $-0.22 | $-0.38 | — | $1.07B |
| 2025-11-03 | Sep 2025 qtr | $-1.12 | $-0.14 | — | $1.78B |
| 2025-08-04 | Jun 2025 qtr | $-2.69 | $-1.82 | — | $307.08M |
| 2025-05-05 | Mar 2025 qtr | $-2.48 | $-1.82 | — | $200.39M |
| 2025-03-10 | Dec 2024 qtr | $0.46 | $1.15 | — | $1.23B |
| 2024-08-05 | Jun 2024 qtr | $-2.19 | $-3.62 | — | $138.38M |
BNTX has beaten consensus EPS in 1 of its last 1 scored quarters.
See BNTX on the live calendar →